Merck reviews

Instability over the last 5 years that leads to direction changes every 8 months (especially in Oncology). Complete incompetence and lack of any vision at the highest management levels (people like Rich Tillyer) -- they use the company to exercise their huge egos, while destroying any real science and innovation. A lot of incompetence at the lower management levels (Executive Directors, Directors). Extreme inefficiency of the decision making process -- all power brokers need to be satisfied, leading to bad decisions. Good scientist and good science are not respected.

Title slashing; bonus reduction; poor technology